Bulletin 2010/35 - European Patent Office
28.12.2012 • Views
Share Embed Flag

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) II.1(1)<br />

(73) Saalmann, Gerhard, Gartenstrasse 19, 32049<br />

Herford, DE<br />

(72) SAALMANN, Gerhard, 32049 Herford, DE<br />

SAALMANN, Peter, 32049 Herford, DE<br />

TRONNIER, Hagen, 58313 Herdecke, DE<br />

(74) Miller, Andreas, Miller Rechtsanwälte<br />

Schreiberstrasse 20, 79098 Freiburg, DE<br />

A61K 31/196 → (51) A61K 31/192<br />

A61K 31/275 → (51) C07C 255/29<br />

A61K 31/28 → (51) A61K 31/192<br />

A61K 31/33 → (51) C07C 255/29<br />

A61K 31/3<strong>35</strong> → (51) C07D 305/12<br />

A61K 31/34 → (51) C07K 14/4<strong>35</strong><br />

A61K 31/343 → (51) A61K 31/192<br />

A61K 31/<strong>35</strong> → (51) C07D 319/06<br />

A61K 31/<strong>35</strong>2 → (51) C07D 311/08<br />

A61K 31/375 → (51) A61K 31/195<br />

A61K 31/381 → (51) A61K 31/192<br />

A61K 31/381 → (51) C07D 409/14<br />

A61K 31/382 → (51) A61K 31/192<br />

A61K 31/40 → (51) A61K 31/167<br />

A61K 31/40 → (51) C07D 207/14<br />

A61K 31/40 → (51) C07D 401/12<br />

A61K 31/40 → (51) C07D 451/04<br />

(51) A61K 31/4162 (11) 2 117 539 B1<br />

A61P <strong>35</strong>/00<br />

(25) En (26) En<br />

(21) 07821854.2 (22) 25.10.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(43) 18.11.2009<br />

(86) EP 2007/061491 25.10.2007<br />

(87) WO 2008/052931 2008/19 08.05.2008<br />

(30) 03.11.2006 EP 06123440<br />

(54) • VERFAHREN ZUR VERABREICHUNG EINER<br />

ANTITUMORALEN VERBINDUNG<br />

• A METHOD OF ADMINISTERING AN<br />

ANTITUMOR COMPOUND<br />

• PROCÉDÉ D'ADMINISTRATION D'UN<br />

COMPOSÉ ANTI-TUMEUR<br />

(73) Nerviano Medical Sciences S.r.l., Viale Pasteur,<br />

10, 20014 Nerviano (MI), IT<br />

(72) LAFFRANCHI, Bernard, 20080 Bubbiano<br />

(Milan), IT<br />

MOLL, Jurgen, 22070 Appiano Gentile<br />

(Como), IT<br />

BOLOGNA, Fabrina, 20010 Pogliano Milanese<br />

(Milan), IT<br />

COMIS, Silvia, 20080 Bubbiano (Milan), IT<br />

A61K 31/4184 → (51) C07D 401/14<br />

(51) A61K 31/4196 (11) 1 720 546 B1<br />

A61P 11/06 C07D 249/08<br />

C07D 405/04<br />

(25) De (26) De<br />

(21) 05707250.6 (22) 08.02.2005<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

(43) 15.11.2006<br />

(86) EP 2005/001232 08.02.2005<br />

(87) WO 2005/077361 2005/34 25.08.2005<br />

(30) 14.02.2004 EP 04003<strong>35</strong>4<br />

(54) • NEUE LANGWIRKSAME BETA-2-AGONIS-<br />

TEN, UND DEREN VERWENDUNG ALS<br />

ARZNEIMITTEL<br />

• NOVEL, SUSTAINED-ACTION BETA-2-<br />

AGONISTS AND THEIR USE AS MEDICA-<br />

MENTS<br />

• NOUVEAUX BETA-2-AGONISTES A<br />

ACTION LONGUE DUREE ET LEUR UTILI-<br />

SATION COMME MEDICAMENTS<br />

(73) Boehringer Ingelheim International GmbH,<br />

Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) AT BE BG CH CY CZ DK EE ES FI FR GB GR<br />

HU IE IS IT LI LT LU MC NL PL PT RO SE SI<br />

SK TR<br />

(73) Boehringer Ingelheim Pharma GmbH & Co.<br />

KG, Binger Strasse 173, 55216 Ingelheim am<br />

Rhein, DE<br />

(84) DE<br />

(72) BOUYSSOU, Thierry, 88447 Birkenhard, DE<br />

HOENKE, Christoph, 55218 Ingelheim, DE<br />

KONETZKI, Ingo, 88447 Warthausen, DE<br />

MACK, Jürgen, 88400 Biberach, DE<br />

SCHNAPP, Andreas, 88400 Biberach, DE<br />

(74) Hammann, Heinz, Boehringer Ingelheim<br />

Pharma GmbH & Co. KG Binger Strasse 173,<br />

55216 Ingelheim am Rhein, DE<br />

A61K 31/42 → (51) C07D 261/12<br />

A61K 31/4<strong>35</strong> → (51) C07D 215/22<br />

A61K 31/4<strong>35</strong> → (51) C07D 215/54<br />

A61K 31/4<strong>35</strong>5 → (51) C07D 471/04<br />

A61K 31/4365 → (51) C07D 495/04<br />

A61K 31/4375 → (51) A61K 31/167<br />

A61K 31/4375 → (51) C07D 471/14<br />

A61K 31/44 → (51) A61K 31/513<br />

A61K 31/44 → (51) C07D 471/04<br />

A61K 31/4436 → (51) C07D 409/14<br />

A61K 31/4439 → (51) C07D 277/34<br />

A61K 31/4439 → (51) C07D 409/14<br />

A61K 31/444 → (51) C07D 409/14<br />

A61K 31/445 → (51) C07D 207/14<br />

A61K 31/445 → (51) C07D 413/12<br />

A61K 31/4453 → (51) A61K 31/167<br />

A61K 31/4523 → (51) C07D 207/14<br />

A61K 31/454 → (51) A61K 31/167<br />

(51) A61K 31/4545 (11) 1 983 987 B1<br />

C07D 401/12 A61P 11/00<br />

A61P 37/08<br />

(25) En (26) En<br />

(21) 07750530.3 (22) 13.02.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

541<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>35</strong>/<strong>2010</strong>) 01.09.<strong>2010</strong><br />

(43) 29.10.2008<br />

(86) US 2007/003699 13.02.2007<br />

(87) WO 2007/095188 2007/34 23.08.2007<br />

(30) 14.02.2006 US 772992 P<br />

17.07.2006 US 831371 P<br />

04.10.2006 US 849<strong>35</strong>3 P<br />

21.12.2006 US 876206 P<br />

(54) • ALS PROTEIN-KINASE-INHIBITOREN<br />

NUTZBARE DYHYDRODIAZEPINE<br />

• DIHYDRODIAZEPINES USEFUL AS INHI-<br />

BITORS OF PROTEIN KINASES<br />

• DIHYDRODIAZEPINES SERVANT D'INHI-<br />

BITEURS DES PROTEINES KINASES<br />

(73) VERTEX PHARMACEUTICALS INCORPO-<br />

RATED, 130 Waverly Street, Cambridge, MA<br />

02139, US<br />

(72) DAMIEN-CHARRIER, Jean, Oxfordshire<br />

OX14 4RY, GB<br />

KAY, David, Oxfordshire OX14 4RY, GB<br />

KNEGTEL, Ronald, Oxfordshire OX14 4RY,<br />

GB<br />

TWIN, Heather, Oxfordshire OX14 4RY, GB<br />

(74) Cohausz & Florack, <strong>Patent</strong>- und Rechtsanwälte<br />

Partnerschaftsgesellschaft Bleichstraße<br />

14, 40211 Düsseldorf, DE<br />

A61K 31/4545 → (51) A61K 31/167<br />

A61K 31/47 → (51) A61K 31/167<br />

A61K 31/47 → (51) C07D 215/12<br />

A61K 31/47 → (51) C07D 311/08<br />

A61K 31/47 → (51) C07D 471/04<br />

A61K 31/4709 → (51) A61K 31/167<br />

A61K 31/4709 → (51) C07D 215/12<br />

A61K 31/4725 → (51) A61K 31/167<br />

A61K 31/4725 → (51) C07D 401/12<br />

A61K 31/495 → (51) C07D 213/71<br />

A61K 31/495 → (51) C07D 401/14<br />

(51) A61K 31/496 (11) 2 010 178 B1<br />

C07D 403/02 C07D 407/14<br />

C07D 401/06 C07D 401/14<br />

(25) En (26) En<br />

(21) 07755237.0 (22) 10.04.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(43) 07.01.2009<br />

(86) US 2007/008901 10.04.2007<br />

(87) WO 2007/120688 2007/43 25.10.2007<br />

(30) 14.04.2006 US 791962 P<br />

(54) • SUBSTITUIERTE IMIDAZOL-4-CARBOXA-<br />

MIDE ALS CHOLECYSTOKININ-1-REZEP-<br />

TOR-MODULATOREN<br />

• SUBSTITUTED IMIDAZOLE 4-CARBOXA-<br />

MIDES AS CHOLECYSTOKININ-1 RECEP-<br />

TOR MODULATORS<br />

• IMIDAZOLE 4-CARBOXAMIDES SUBSTI-<br />

TUES UTILISES EN TANT QUE MODULA-<br />

TEURS DES RECEPTEURS DE<br />

CHOLECYSTOKININE-1<br />

(73) Merck Sharp & Dohme Corp., 126 East<br />

Lincoln Avenue, Rahway, NJ 07065, US<br />

(72) BERGER, Richard, Rahway, New Jersey<br />

07065-0907, US<br />

EDMONDSON, Scott, Rahway, New Jersey<br />

07065-0907, US<br />

HANSEN, Alexa, Danville, CA 94526, US<br />

ZHU, Cheng, Rahway, New Jersey 07065-<br />

0907, US

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!